By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

Shares in Valneva slumped around 25% on Monday after the French drugmaker said the United States Food and Drug Administration ...

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...

US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of ...

The cities of Foshan and Guangzhou, in southern China, have been battling the virus for two months. Nearly 10,000 cases have ...

DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of ...

I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful for her for ...

Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an ...

The FDA suspended Valneva’s U.S. license for its chikungunya vaccine Ixchiq due to serious safety concerns, multiple ...